Stavanger UncomPlicatEd Elective PCI Same DaY Discharge Study (SPEEDY Study)

Helse Stavanger HF82 enrolled

Overview

The purpose of this study is to provide information on safety of same day discharge after uncomplicated percutaneous intervention (PCI) for stable angina pectoris in Norwegian clinical practice. The investigators also think that is in patients interest to stay as short time as possible in hospital and this will be measured using standardised quality of life questionnaires.

The international literature has already provided documentation on the safety of same day discharge in various clinical scenario. In this particular study, the investigators focus on challenging the contemporary Norwegian practice where every body stays over night. Only patients with stable angina pectoris will be included in the study. After informed consent and successful procedure, the patients will be randomised to same day discharge or standard care. Same day discharge patients will be contacted by telephone the day after the procedure for follow-up conversation with particular emphasis on access site complications. Both groups will receive quality of life questionnaire within a month for assessment of difference between the two strategies.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Enrollment

Conditions

Coronary Artery Disease

Interventions

same day dischargePROCEDURE

same day discharge after PCI for stable CAD

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Elective procedures Monday through Thursday * Patient consenting for same day discharge * Operator has assessed the patient and is in agreement * Adequate observational facility * Uncomplicated procedure * Acceptable social network at home * Uneventful post PCI ECG * Adequate hemostasis of puncture site Exclusion Criteria: * Angiographic * No-reflow/slow flow post PCI * Sub-optimal PCI result * Dissection type C-E * Rest dissection after stent deployment * Angiographic thrombus * Guidewire perforation * Clinical * Advanced age * Severe renal failure (GFR \< 30ml/min) * Excessive bleeding risk * Symptomatic heart failure * Severe visual or hearing impairment * Multi-vessel PCI (2 main vessels or left main) * Use of GP IIb/IIIa inhibitors * Social * Living alone or has no telephone * Long driving distance (\> 30-45 min) * Patient/next to keen can´t communicate with health personnel without a translator

Locations (1)

Stavanger University Hospital

Stavanger, Rogaland, Norway

Outcomes

Primary Outcomes

number of complications (access site bleeding)

observation of complications requiring intervention

Time frame: 1 month

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.